# A Study to Evaluate the Efficacy and Safety of HRS4800 Tablets for Postoperative Analgesia After Impacted Teeth Removal Surgery.

> **NCT05318846** · PHASE2 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 38 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** HRS4800 tablets
- **DRUG:** Placebo tablets

## Key facts

- **NCT ID:** NCT05318846
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-14
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-03-22
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2022-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05318846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05318846, "A Study to Evaluate the Efficacy and Safety of HRS4800 Tablets for Postoperative Analgesia After Impacted Teeth Removal Surgery.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05318846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*